查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1423596

男性女乳症手術的全球市場預測（~2030 年）：按手術類型、最終用戶和地區進行分析

Gynecomastia Procedures Market Forecasts to 2030 - Global Analysis By Procedure Type (Excision, Liposuction, Mastectomy and Minimal Incision Technique), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

2023年全球男性女乳症手術市場規模為8.983億美元，預估預測期間內複合年成長率為10.8%，至2030年達到18.417億美元。男性女乳症或男性乳房增大可能是由荷爾蒙失衡、某些藥物、肥胖或其他醫療狀況引起的。

這種被稱為男性女乳症手術的手術技術旨在透過去除多餘的乳房組織來幫助男性獲得更有男子氣概、更有雕塑感的胸部外觀。在進行手術之前，您應該諮詢有執照的整形外科醫生或其他醫療保健提供者，以確定適合您的特定情況和期望結果的最佳行動方案。

意識和接受度不斷提高

隨著男性女乳症變得越來越為人所知，越來越多受影響的人正在了解治療方案。由於對男性女乳症的了解不斷增加，越來越多的人尋求醫療干預來解決外觀問題和相關的心理影響，因此對男性女乳症手術的需求量很大。保險公司和醫療保健系統可能會發生變化以承保男性女乳症手術。隨著越來越多的人發現這些治療方法更便宜、更容易獲得，保險覆蓋範圍和融資選擇的改善可能會推動市場成長。

手術費用高

當談到擇期手術時，患者的決定很大程度上取決於他們的支付能力。高昂的費用可能會阻礙患者接受男性女乳症手術。因此，過高的定價導致男性女乳症治療的差異化可能會加劇健康差距。難以獲得重症監護的邊緣化群體和經濟貧困群體可能會加劇健康差距。

醫療科技的進步

由於醫療技術的進步，新的男性女乳症治療方法正在研究和開發。這包括超音波能量、射頻輔助裝置和其他最尖端科技的應用，旨在提供補充或取代傳統手術技術的策略。此外，遠端醫療和遠距會診使農村地區和專業醫療設施有限的地區的患者更容易獲得專家意見和諮詢。對於男性女乳症患者來說，這種廣泛的訪問可以改善獲得資訊和可能的治療方法。

文化偏見和認知

男性女乳症患者可能會推遲就醫，因為擔心因恥辱或文化偏見而受到評判或羞辱。延誤就醫可能會使病情惡化，並對人們的身心健康產生負面影響。由於缺乏對男性女乳症是一種可透過醫學治癒的疾病和許多人可能不知道的合法醫療問題的認知和接受，導致報告不足和手術需求減少，從而導致市場可能會阻礙其成長。

COVID-19 的影響

許多選擇性手術，包括男性女乳症治療，在大流行最嚴重的時候被推遲或取消，以便將資源集中在 COVID-19 患者身上。為了節省醫療資源並降低病毒感染的風險，醫院和診所已被指示限制不必要的手術數量。全球衛生系統已經將注意力和資源從男性女乳症治療等選擇性手術上轉移，以控制和遏制病毒的傳播。

預計抽脂細分市場將在預測期內成為最大的細分市場

由於抽脂手術是一種常見的手術方法，用於治療因脂肪堆積過多而導致男性乳房增大的主要原因，因此抽脂領域預計將出現良好的成長。抽脂手術是市面上流行且成功的男性女乳症手術方法，特別是在過量脂肪堆積是男性女乳症主要原因的情況下。然而，有必要諮詢有執照的整形外科醫生或其他醫療專業人士，根據每位患者的獨特情況和期望的結果選擇最佳的治療方案。

預計整容中心細分市場在預測期內複合年成長率最高

整容手術中心根據每位客戶的具體要求提供獨特的手術。抽脂手術、腺體組織切除術、內視鏡手術或根據患者情況組合使用多種方法。這些診所聘請了擅長男性女乳症治療的整形外科醫生和醫療專業人員。他們確保最佳結果、病人安全並遵守專業標準。在治療期間，我們保持謹慎和專業的環境，並注重患者的隱私和保密。

比最大的地區

由於北美地區注重先進的醫療基礎設施、嚴格的法規、患者安全和護理質量，並且重要公司的存在是區域擴張的促進因素，預計北美地區將在預測期內實現成長。預計將佔據最大的市場佔有率。此外，由於醫療設施的便利性和可支配收入相對較高，人們可以更容易獲得男性女乳症的治療。該行業的競爭透過促進創新和確保高標準的護理來進一步鞏固該地區的優勢，從而推動該地區的市場成長。

複合年成長率最高的地區

預計亞太地區在預測期內的複合年成長率最高。這是因為，隨著亞太地區對男性女乳症及其治療方法的認知不斷提高，與男性女乳症相關的恥辱感正在逐漸消失，導致人們對治療的接受度更高，需求也更強烈。此外，亞太地區近年來經歷了顯著的經濟成長，人口可支配收入的增加加速了該地區的市場擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球男性女乳症手術市場：依手術類型

  • 切除
  • 抽脂手術
  • 切除術
  • 最小切口技術

第6章全球男性女乳症手術市場：依最終使用者分類

  • 美容整形中心
  • 醫院

第7章全球男性女乳症手術市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第8章 主要進展

  • 協議、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章 公司簡介

  • Sun Pharmaceuticals Industries Ltd
  • Cadila Pharmaceuticals Ltd
  • Biochem Pharmaceutical Industries Ltd
  • Zydus Cadila Healthcare Ltd
  • Micro Nova Pharmaceuticals Ltd
  • Kee Pharma Ltd
  • Dr. Reddy's Laboratories Ltd
  • Vyaire Medical
  • MicroAire Surgical Instruments
  • Bausch Health Companies
  • Stryker Corporation
  • Lumenis
  • Johnson & Johnson
  • Cutera
  • GALDERMA
  • Cynosure
  • AbbVie Inc.
Product Code: SMRC24830

According to Stratistics MRC, the Global Gynecomastia Procedures Market is accounted for $898.3 million in 2023 and is expected to reach $1841.7 million by 2030 growing at a CAGR of 10.8% during the forecast period. Gynecomastia, or male breast enlargement, can be brought on by hormone imbalances, certain drugs, obesity, or other medical disorders. Surgical techniques known as gynecomastia operations are designed to help men achieve a more manly and sculpted chest look by removing extra breast tissue. People should speak with a licensed plastic surgeon or other healthcare provider before having any operation done in order to determine the best course of action for their particular situation and desired results.

Market Dynamics:

Driver:

Increasing awareness and acceptance

As gynecomastia becomes better known, more people who are impacted by it learn about their choices for treatment. As more people seek medical intervention to address their worries about appearance and the psychological effects that go along with it, there is a greater demand for gynecomastia operations as a result of this heightened knowledge. Insurance companies and healthcare systems may change to provide coverage for gynecomastia operations. A wider group of people may find these therapies more inexpensive and accessible with improved insurance coverage or financing alternatives driving the growth of the market.

Restraint:

High procedure costs

When it comes to elective operations, patients' decisions are heavily influenced by affordability. Exorbitant expenses may cause patients to seek fewer gynecomastia operations, which would have an impact on the market if people choose not to pursue therapy because of budgetary difficulties. Thus health disparities may be exacerbated by differences in access to gynecomastia treatments brought on by exorbitant pricing. Healthcare disparities may be exacerbated for members of marginalized or economically poor populations who may find it difficult to obtain critical treatments.

Opportunity:

Advancements in medical technology

New gynecomastia treatment approaches are being investigated and developed as a result of ongoing breakthroughs in medical technology. This covers the application of ultrasonic energy, radiofrequency-assisted devices, and other cutting-edge technologies that seek to offer complementary or alternative strategies to conventional surgical techniques. Moreover, patients in rural locations or places with limited access to specialized healthcare facilities now have more access to expert views and consultations thanks to telemedicine and teleconsultation. For those with gynecomastia, this wider reach improves access to information and possible therapies.

Threat:

Cultural stigma and perception

People who are affected with gynecomastia may put off seeking medical attention out of stigma and cultural preconceptions because they are afraid of being judged or embarrassed. Delays can make the illness worse and have an adverse effect on people's physical and emotional health. Lack of knowledge or acceptance of gynecomastia as a legitimate medical problem which is a medically curable condition that many people may be unaware of, which might result in underreporting and a decline in the demand for operations thus hamper the growth of the market.

Covid-19 Impact

In order to concentrate resources for COVID-19 patients, numerous elective operations, including gynecomastia treatments, were postponed or cancelled during the height of the pandemic. In an effort to save medical resources and lower the danger of virus transmission, hospitals and clinics were instructed to restrict the number of unnecessary procedures. Global healthcare systems directed their attention and resources away from elective surgery, such as gynecomastia treatments, in order to manage and control the virus's spread.

The liposuction segment is expected to be the largest during the forecast period

The liposuction segment is estimated to have a lucrative growth, as liposuction is a popular surgical method used to treat cases where the buildup of extra fat is the main cause of male breast enlargement. Liposuction is a popular and successful method in the market for gynecomastia procedures, particularly in situations where the buildup of extra fat is the primary cause of gynecomastia. However, in order to choose the best course of action based on each patient's unique situation and desired results, it is imperative to speak with a licensed plastic surgeon or other healthcare professional.

The cosmetic surgical centers segment is expected to have the highest CAGR during the forecast period

The cosmetic surgical centers segment is anticipated to witness the highest CAGR growth during the forecast period, Cosmetic surgery facilities provide unique operations catered to the specific requirements of each customer. These might involve liposuction, excision of glandular tissue, endoscopic procedures, or a mix of methods according to the patient's condition. Board-certified cosmetic surgeons and medical professionals skilled in gynecomastia treatments work at these clinics. They guarantee the best possible results, patient safety, and professional standards compliance. Throughout the course of therapy, they keep a discreet and professional atmosphere, placing a high value on patient privacy and confidentiality.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to the sophisticated healthcare infrastructure, strict regulations, focus on patient safety and quality of care and presence of important companies are the drivers driving the regional expansion. Furthermore, people can seek gynecomastia therapies more easily due to the increased accessibility to healthcare facilities and comparatively larger disposable expenditures. The rivalry in this sector further solidifies the region's supremacy by fostering innovation and ensuring a high level of treatment driving the growth of the market in this region.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to rising knowledge of gynecomastia and its treatment choices is developing in the Asia Pacific area, so the stigma associated with gynecomastia is progressively disappearing, leading to more acceptability and a stronger demand for therapies. In addition, the Asia Pacific area has had notable economic expansion in recent times, which has led to a rise in the population's disposable income, hence augmenting market expansion in the area.

Key players in the market

Some of the key players profiled in the Gynecomastia Procedures Market include Sun Pharmaceuticals Industries Ltd, Cadila Pharmaceuticals Ltd, Biochem Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd, Dr. Reddy's Laboratories Ltd, Vyaire Medical, MicroAire Surgical Instruments, Bausch Health Companies, Stryker Corporation, Lumenis, Johnson & Johnson, Cutera, GALDERMA, Cynosure and AbbVie Inc.

Key Developments:

In December 2023, AbbVie Inc. and Cerevel Therapeutics announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its robust neuroscience pipeline

In November 2023, Johnson & Johnson MedTech1 announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).

In July 2023, Cadila Pharma launches Posaconazole for treatment of fungal diseases, The drug has also been recommended as a second line treatment for Mucormycosis or black fungus as it is commonly known.

Procedure Types Covered:

  • Excision
  • Liposuction
  • Mastectomy
  • Minimal Incision Technique

End Users Covered:

  • Cosmetic Surgical Centers
  • Hospitals

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gynecomastia Procedures Market, By Procedure Type

  • 5.1 Introduction
  • 5.2 Excision
  • 5.3 Liposuction
  • 5.4 Mastectomy
  • 5.5 Minimal Incision Technique

6 Global Gynecomastia Procedures Market, By End User

  • 6.1 Introduction
  • 6.2 Cosmetic Surgical Centers
  • 6.3 Hospitals

7 Global Gynecomastia Procedures Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Sun Pharmaceuticals Industries Ltd
  • 9.2 Cadila Pharmaceuticals Ltd
  • 9.3 Biochem Pharmaceutical Industries Ltd
  • 9.4 Zydus Cadila Healthcare Ltd
  • 9.5 Micro Nova Pharmaceuticals Ltd
  • 9.6 Kee Pharma Ltd
  • 9.7 Dr. Reddy's Laboratories Ltd
  • 9.8 Vyaire Medical
  • 9.9 MicroAire Surgical Instruments
  • 9.10 Bausch Health Companies
  • 9.11 Stryker Corporation
  • 9.12 Lumenis
  • 9.13 Johnson & Johnson
  • 9.14 Cutera
  • 9.15 GALDERMA
  • 9.16 Cynosure
  • 9.17 AbbVie Inc.

List of Tables

  • Table 1 Global Gynecomastia Procedures Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 3 Global Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
  • Table 4 Global Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
  • Table 5 Global Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
  • Table 6 Global Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
  • Table 7 Global Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
  • Table 8 Global Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
  • Table 9 Global Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 10 North America Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
  • Table 11 North America Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 12 North America Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
  • Table 13 North America Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
  • Table 14 North America Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
  • Table 15 North America Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
  • Table 16 North America Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 North America Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
  • Table 18 North America Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 19 Europe Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
  • Table 20 Europe Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 21 Europe Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
  • Table 22 Europe Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
  • Table 23 Europe Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
  • Table 24 Europe Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
  • Table 25 Europe Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Europe Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
  • Table 27 Europe Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 28 Asia Pacific Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
  • Table 29 Asia Pacific Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 30 Asia Pacific Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
  • Table 31 Asia Pacific Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
  • Table 32 Asia Pacific Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
  • Table 33 Asia Pacific Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
  • Table 34 Asia Pacific Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 Asia Pacific Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
  • Table 36 Asia Pacific Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 37 South America Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 South America Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 39 South America Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
  • Table 40 South America Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
  • Table 41 South America Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
  • Table 42 South America Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
  • Table 43 South America Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
  • Table 44 South America Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
  • Table 45 South America Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 46 Middle East & Africa Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
  • Table 47 Middle East & Africa Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
  • Table 48 Middle East & Africa Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
  • Table 49 Middle East & Africa Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
  • Table 50 Middle East & Africa Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
  • Table 51 Middle East & Africa Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
  • Table 52 Middle East & Africa Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
  • Table 53 Middle East & Africa Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
  • Table 54 Middle East & Africa Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)